Researchers have identified two receptors called CB1 and CB2 to which marijuana molecules attach. Receptors are specialized cells that respond to specific stimuli or changes in the environment. Public health experts expect the new WHO code to dramatically improve surveillance and help physicians spot trends, especially as legalization spreads and high-potency products proliferate. “My hope would be that with this new diagnosis code that CHS is more accurately diagnosed in an emergency room setting,” he said.
These genes impact the TRPV1 receptor, dopamine receptors, and the enzyme CYP2C9 (which is responsible for metabolising THC in the liver). Each of these genes impact some aspect of cannabinoid metabolism or CHS symptomatology—suggesting that this isn’t a coincidence. In other words, the drug you might use to treat nausea in low doses can have the opposite effect in high doses over time. And unfortunately, since so many people believe that marijuana eases nausea, people with cannabinoid hyperemesis syndrome might turn to marijuana in a misguided attempt to get relief. During the study period, roughly 100,000 cases of suspected CHS were documented. Prior to the covid-19 pandemic, they found, annual rates of CHS were steady.
Researchers say isolation, stress and increased access to high-potency cannabis products likely contributed to the rise. Following the hyperemetic phase is the recovery phase, in which patients resume normal eating patterns and symptoms begin to improve. CHS is a cyclical three-phase (prodromal, hyperemetic or vomiting, and recovery) syndrome.
While these are all just theories, they make sense with what we know about cannabis and its impact on the human body. Cannabinoid Hyperemesis Syndrome (aka CHS) is a rare form of non-stop vomiting related to too drug addiction much cannabis use.Read about the history, prevalence, causes, and cures in this expert research review. It’s common for people to lose weight during the hyperemetic phase. Nausea suppresses your appetite, and anything you do eat comes right back up again.
It’s important to be honest about your marijuana use if you have symptoms of CHS. Without knowing this background, providers often misdiagnose CHS as other conditions, like cyclic vomiting syndrome (CVS). Increasing numbers of heavy cannabis consumers are reported to be suffering severe nausea, vomiting, and intestinal cramps from a condition known as cannabis hyperemesis syndrome (CHS). CHS treatment revolves around symptom management and cannabis cessation.
Starting in 2020, however, suspected cases of CHS seen in the ER surged. And though cases did decline in 2022, they were still above the pre-pandemic baseline. Importantly, cases of cannabis-related health problems in general also rose during that same period, while cases of cyclical vomiting syndrome without any cannabis link did not, further suggesting a real rise in CHS. CHS usually starts after years of using marijuana many times a week. Initial symptoms are feeling sick to the stomach, belly pain and the feeling like you may throw up.
During this time, symptoms subside and patients https://ecosoberhouse.com/ will regain their appetite. If a patient consumes cannabis again after recovering from CHS, there is a high potential that symptoms will return and they will re-enter the prodromal phase of the illness. In addition, THC is lipid-binding and can be stored within the body’s fat cells to potentially toxic levels with repeated, frequent use.
Interestingly, patients dealing with Cyclical Vomiting Syndrome (CVS) also frequently mention this behavior. Yet, with the evolving comprehension of CHS, there is a likelihood that some cases attributed to CVS might actually be undiagnosed instances of CHS, marking it as pathognomonic. This underscores the critical need to correlate symptoms with cannabis consumption, ruling out overlapping diagnoses that could be mistaken for CVS. This means that getting diagnosed could be key to preventing other health risks for this vulnerable population.
One area of research focuses on potential pharmacological treatments. Scientists are investigating chs without vomiting drugs that interact with the endocannabinoid system in different ways, hoping to find something that can prevent or treat CHS without requiring complete cannabis cessation. It’s like trying to develop a vaccine for a virus – challenging, but potentially game-changing.